Loeb S, Cooperberg MR. “Early Detection of Prostate Cancer.” Urological Clinics of North America 2014 May epub. PMID: 24725496 Link: http://www.ncbi.nlm.nih.gov/pubmed/24725496
Loeb S, Cooperberg MR. “Early Detection of Prostate Cancer.” Urological Clinics of North America 2014 May epub. PMID: 24725496 Link: http://www.ncbi.nlm.nih.gov/pubmed/24725496
Loeb S, Bruinsma SM, Nicholson J, Briganti A, Pickles T, Kakehi Y, Carlsson SV, Roobol MJ. “Active Surveillance for Prostate Cancer: A Systematic Review of Clinicopathologic Variables and Biomarkers for Risk Stratification.” European Urology 2014 Oct epub. PMID: 25457014 Link: http://www.ncbi.nlm.nih.gov/pubmed/25457014
Loeb S. “Time to replace prostate-specific antigen (PSA) with the Prostate Health Index (PHI)? Yet more evidence that PHI consistently outperforms PSA across diverse populations.” BJU International 2015; 115: 500. PMID: 25808708 Link: http://www.ncbi.nlm.nih.gov/pubmed/25808708
Loeb S, Sokoll LJ, Broyles DL, Bangma CH, van Schaik RH, Klee GG, Wei JT, Sanda MG, Partin AW, Slawin KM, Marks LS, Mizrahi IA, Shin SS, Cruz AB, Chan DW, Roberts WL, Catalona WJ. “Prospective Multicenter Evaluation of the Beckman Coulter Prostate Health Index Using WHO Calibration.” Journal of Urology 2012; epub November. PMID:… Read More
Vellekoop A and Loeb S. “Update of Randomized Trials for Prostate Cancer Screening.” Reviews in Urology 2013; 15: 37-9. PMID: 23671404 Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651541/
Loeb S. “Prostate cancer: Predicting prostate biopsy results- PCA3 versus phi.” Nature Reviews Urology 2015 epub Feb 3. PMID: 25644161 Link: http://www.ncbi.nlm.nih.gov/pubmed/25644161
Tosoian JJ, Loeb S, Feng Z, Isharwal S, Landis P, Elliot DJ, Veltri R, Epstein JI, Partin AW, Carter HB, Trock B, Sokoll LJ. “Association of [-2]proPSA with Biopsy Reclassification During Active Surveillance for Prostate Cancer.” Journal of Urology 2012; 188: 1131-6. PMID: 22901577. Link: http://www.ncbi.nlm.nih.gov/pubmed/22901577
Loeb S “Use of Baseline Prostate-Specific Antigen Measurements to Personalize Prostate Cancer Screening.” European Urology May 2012: 61: 875-6. PMID:22154726. Link: http://www.ncbi.nlm.nih.gov/pubmed/22154726
Lundon D, Loeb S. “Prostate-Specific Antigen Velocity Risk Count to Discern Significant From Indolent Prostate Cancer.” Reviews in Urology 2014; 16: 154. PMID: 25337050. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191640/
Loeb S. “Editorial Comment on: A Commentary on PSA Velocity and doubling time for clinical decisions in prostate cancer” Urology 2014; 83: 596. PMID: 24581522 Link: http://www.ncbi.nlm.nih.gov/pubmed/24581522
Loeb S. Editorial Comment on “Low percentage of free prostate-specific antigen (PSA) is a strong predictor of later detection of prostate cancer among Japanese men with serum levels of total PSA of 4.0 ng/mL or less” Urology 2014; 84: 1167. PMID: 25443924. Link: http://www.ncbi.nlm.nih.gov/pubmed/25443924
Nichols JH, Loeb S, Metter EJ, Ferrucci L, Carter HB. “The Relationship Between Prostate Volume and Prostate-Specific Antigen Variability: Data from the Baltimore Longitudinal Study of Aging and the Johns Hopkins Active Surveillance Program.” BJU International 2012; 109: 1304-8. PMID: 22093443. Link: http://www.ncbi.nlm.nih.gov/pubmed/22093443
Loeb S, Catalona WJ. “The Prostate Health Index: A New Test for the Detection of Prostate Cancer.” Therapeutic Advances in Urology 2014; 6: 74. PMID: 24688603 Link: https://pubmed.ncbi.nlm.nih.gov/24688603/
Roobol MJ, Bangma CH, Loeb S. “Prostate-specific antigen screening can be beneficial to younger and at-risk men.” CMAJ, May 2012 epub. PMID: 22566532. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537779/
Dr. Loeb Hosts the Men’s Health Show on US/Canada satellite radio Sirius XM channel 110 On Wednesdays from 6-8pm EST. https://www.siriusxm.com/doctorradio/weeklyschedule
Ever since a paper was released last year detailing cases of melanoma found in men taking the billion-dollar erectile dysfunction (ED) blockbuster Viagra, urologist Stacy Loeb of New York University has been fielding questions from worried patients about whether they should risk the little blue pill…
Loeb S, Bruinsma SM, Nicholson J, Briganti A, Pickles T, Kakehi Y, Carlsson SV, Roobol MJ. “Active Surveillance for Prostate Cancer: A Systematic Review of Clinicopathologic Variables and Biomarkers for Risk Stratification.” European Urology 2014 Oct epub. PMID: 25457014 Link: http://www.ncbi.nlm.nih.gov/pubmed/25457014
Loeb S, Folkvaljon Y, Lambe M, Robinson D, Garmo H, Ingvar C, Stattin P. “Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.” JAMA 2015; 313: 2449-55. PMID: 26103029. Link: http://www.ncbi.nlm.nih.gov/pubmed/26103029
8/2013 Australia TV appearance video http://mobile.abc.net.au/news/2013-08-06/new-blood-test-offers-improved-treatment-for/4867150
6/2014 Arise TV appearance on prostate cancer
5/2015 ASCO/MedPage Today video on Active Surveillance http://www.medpagetoday.com/ASCOVideoConferenceReporterAUA/special-reports/AUA2015Video-Videos/1143
Seminar on prostate cancer screening at Laura and Isaac Perlmutter NYU Cancer Center
2/2015 Global Congress on Prostate Cancer Panel Discussion: “Turning the tables: putting the expert in the patient’s seat” http://library.mirrorsmed.org/sessions/turning-tables-putting-expert-patients-seat
2/2015 Global Congress on Prostate Cancer Lecture on Screening and Early Diagnosis of Prostate Cancer http://library.mirrorsmed.org/sessions/screening-and-early-diagnosis-prostate-cancer
10/2015 Cancer Research and Oncology Virtual Conference: Lecture on Active Surveillance: Trends in Use, Patient Selection & Monitoring September 30, 2015 Lecture topic: Active Surveillance: Trends in Use, Patient Selection and Monitoring Category: prostate cancer Location: online
Roobol MJ, van Vugt HA, Loeb S, Zhu X, Bul M, Bangma CH, van Leenders AG, Steyerberg EW, and Schroder FH. “Prediction of Prostate Cancer Risk: The Role of Prostate Volume and Digital Rectal Examination in the ERSPC Risk Calculators.” European Urology 2012; 61: 577-83. PMID: 22104592. Link: http://www.ncbi.nlm.nih.gov/pubmed/22104592
Loeb S, Carlsson S, and Braithwaite RS. “Prostate Cancer: Modeling the Outcomes of Prostate Cancer Screening.” Nature Reviews Urology, March 2012; 13: 183-5. PMID: 224106678. Link: http://www.ncbi.nlm.nih.gov/pubmed/22410678
Bratt O, Folkvaljon Y, Hjalm Eriksson M, Akre O, Carlsson S, Drevin L, Franck Lissbrant I, Makarov D, Loeb S, Stattin P. “Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.” European Urology 2015 epub. PMID: 25813688. Link: http://www.ncbi.nlm.nih.gov/pubmed/25813688 Using data from national Swedish registries, this study showed that many healthy men in… Read More
Mullins JK, Feng Z, Trock BJ, Epstein JI, Walsh PC, Loeb S. “The Impact of Anatomical Radical Retropubic Prostatectomy on Cancer Control: The 30-Year Anniversary.” Journal of Urology epub October 18, 2012. PMID: 23083655. Link: http://www.ncbi.nlm.nih.gov/pubmed/23083655 A total of 4,478 men underwent anatomical radical retropubic prostatectomy by Dr Patrick C. Walsh at the Johns Hopkins… Read More
Loeb S, Zhu X, Schroder FH, Roobol MJ. “Long-term radical prostatectomy outcomes among participants from the European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam.” BJU International epub Sept 21, 2012. PMID: 22998182. Link: http://www.ncbi.nlm.nih.gov/pubmed/22998182 This study compared the outcomes of prostate cancer treatment between men in the screening and control arms of the… Read More
Loeb S, Ribal MJ. “Controversies in Management of High-Risk Prostate and Bladder Cancer.” BJU International 2015 Nov; 116: 675. PMID: 26449166. Link: http://www.ncbi.nlm.nih.gov/pubmed/26449166
Bjurlin MA, Walter D, Taksler GB, Huang WC, Wysock JS, Sivarajan G, Loeb S, Taneja SS, Makarov DV. “National Trends in the Utilization of Partial Nephrectomy Before and After the Establishment of AUA Guidelines for the Management of Renal Masses.” Urology 2013; 82: 1283-9. PMID: 24295245. Link: http://www.ncbi.nlm.nih.gov/pubmed/24295245
Bangma CH, Loeb S, Susstra M, Zhu X, Bouazzaoui SE, Refos J, Van Der Keur KA, Tijn S, Franken CG, van Leenders GJ, Zwarthoff EC, Roobol MJ. “Outcomes of a Bladder Cancer Screening Program Using Home Hematuria Testing and Molecular Markers.” European Urology 2013 epub March 4. PMID: 23478169 Link: http://www.ncbi.nlm.nih.gov/pubmed/23478169
Bivalacqua TJ, Loeb S, Pierorazio PM, Schoenberg MP, Partin AW, Guzzo TJ. “Is Prostate Specific Antigen Surveillance Necessary in Men with Benign Prostate Pathology Following Radical Cystoprostatectomy for Bladder Cancer?” Urologia Internationalis epub November 2010; 85: 466. Link: http://www.ncbi.nlm.nih.gov/pubmed/21071926
Loeb S, Lotan T, Thornton K, and Schoenberg MP. “A Case of Gastrointestinal Stromal Tumor Diagnosed on Prostate Biopsy.” Nature Clinical Practice Urology, December 2008 (epub). Link: http://www.ncbi.nlm.nih.gov/pubmed/19048005
Macejko AM, Pazona JF, Loeb S, Kimm S, and Nadler RB. “Management of Distal Ureter in Laparoscopic Nephroureterectomy- A Comprehensive Review of Techniques.” Urology 2008 (epub). Link: http://www.ncbi.nlm.nih.gov/pubmed/18602140
Zhao LC, Han JS, Loeb S, Tenggardjaja C, Rubenstein R, Smith ND, and Nadler RB. “Thoracic Complications of Urological Laparoscopy: Correlation Between Radiographic Findings and Clinical Manifestations.” J Endourol 2008; 22: 607. Link: http://www.ncbi.nlm.nih.gov/pubmed/18419207